Correspondence 0001683168-24-007475 from Xenetic Biosciences, Inc. (XBIO) (CIK 0001534525) (XBIO)
Xenetic Biosciences, Inc. (XBIO) (CIK 0001534525)
Date: Oct. 30, 2024 · CIK: 0001534525 · Accession: 0001683168-24-007475
AI Filing Summary & Sentiment
File numbers found in text: 333-282756
Letter
945 Concord Street
Framingham, Massachusetts 01701
October 30, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Chris Edwards
Re: Xenetic Biosciences, Inc. Registration Statement on Form S-3 (File No. 333-282756)
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations promulgated under the Securities Act of 1933, as amended, Xenetic Biosciences, Inc. hereby requests that its Registration Statement on Form S-3 (File No. 333-282756) filed with the Securities and Exchange Commission (the “Commission”) on October 21, 2024, be declared effective by the Commission at 5:00 p.m. Eastern Time on Friday, November 1, 2024, or as soon thereafter as practical.
Once the Registration Statement is declared effective, please orally confirm that event with our counsel, Holland & Knight LLP, by calling Danielle Price at (305) 349-2259.
Thank you for your assistance.
Sincerely,
/s/ James Parslow
Show Raw Text
CORRESP 1 filename1.htm 945 Concord Street Framingham, Massachusetts 01701 October 30, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Chris Edwards Re: Xenetic Biosciences, Inc. Registration Statement on Form S-3 (File No. 333-282756) Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations promulgated under the Securities Act of 1933, as amended, Xenetic Biosciences, Inc. hereby requests that its Registration Statement on Form S-3 (File No. 333-282756) filed with the Securities and Exchange Commission (the “Commission”) on October 21, 2024, be declared effective by the Commission at 5:00 p.m. Eastern Time on Friday, November 1, 2024, or as soon thereafter as practical. Once the Registration Statement is declared effective, please orally confirm that event with our counsel, Holland & Knight LLP, by calling Danielle Price at (305) 349-2259. Thank you for your assistance. Sincerely, /s/ James Parslow James Parslow Interim Chief Executive Officer and Chief Financial Officer